Sebia sells electrophoresis instruments and protein-based IVDs for use in multiple myeloma as well as metabolic, autoimmune, and inflammatory conditions.

As the shutdown drags out, there could be delays in regulatory processes and payments for medical services as well as the possibility that legislative priorities will go unaddressed.

The University of Washington spinout's test is used to detect and analyze protein biomarkers in a low-cost test, with results in 15-minutes.

Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...

The firm reported Wednesday that its third quarter Diagnostics revenues declined nearly 7 percent year over year.

An explosion in Medicare spending on epilepsy testing resembles a pattern of improper payments for genetic testing that was ...

Researchers hope to soon commercialize a simple, inexpensive, and accessible screening test that uses taste as a detection tool for presymptomatic flu infections.

Saliva, sweat, and interstitial fluid have shown promise as alternative sample types in situations where blood may be too hard to access.

The test is intended for patients ages 55 and older presenting with signs, symptoms, or complaints of cognitive decline.

Last week, readers were most interested in a story about Meridian Bioscience's two-pronged approach to fuel its success.

The firm is leading a collaborative project on the development of a test to detect markers of 36 types of cancer in breath and urine samples.